Ilse Weets
About
In The Last Decade
Ilse Weets
92 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 1.4k
- Genetics 1.3k
- Surgery 1.1k
- Speech and Hearing 262
- Immunology 234
Countries citing papers authored by Ilse Weets
This map shows the geographic impact of Ilse Weets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse Weets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse Weets more than expected).
Fields of papers citing papers by Ilse Weets
This network shows the impact of papers produced by Ilse Weets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse Weets. The network helps show where Ilse Weets may publish in the future.
Co-authorship network of co-authors of Ilse Weets
This figure shows the co-authorship network connecting the top 25 collaborators of Ilse Weets. A scholar is included among the top collaborators of Ilse Weets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse Weets. Ilse Weets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 12 | |
| 4 | 18 | |
| 5 | 15 | |
| 6 | Pre-existing insulin autoantibodies predict efficacy of otelixizumab in preserving residual beta cell function in recent-onset type 1 diabetes | 4 |
| 7 | 19 | |
| 8 | 25 | |
| 9 | Seroconversion to persistent islet autoantibody-positivity can occur at all ages, is best predicted by glutamate decarboxylase antibodies and is strongly associated with progression to diabetes | 1 |
| 10 | Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres | 1 |
| 11 | 35 | |
| 12 | 7 | |
| 13 | 16 | |
| 14 | 15 | |
| 15 | 19 | |
| 16 | HLA-DQ restricted progression to clinical onset in antibody-positive first degree relatives of type 1 diabetic patients | 1 |
| 17 | 13 | |
| 18 | Le diabete de type 1: Une maladie auto-immune heterogene, predictible, evitable, guerissable? | 1 |
| 19 | Manifestations inaugurales du diabète de type 1 chez l'enfant, l'adolescent et l'adulte de moins de 40 ans | 3 |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.